These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24346887)

  • 1. Eumycetoma by Madurella mycetomatis with 30 years of evolution: therapeutic challenge.
    Sampaio FM; Galhardo MC; Quintella LP; Souza PR; Coelho JM; Valle AC
    An Bras Dermatol; 2013; 88(6 Suppl 1):82-4. PubMed ID: 24346887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Madurella mycetomatis infection of the buttock in an Eritrean refugee in Switzerland: a case report.
    Mekoguem C; Triboulet C; Gouveia A
    J Med Case Rep; 2019 Feb; 13(1):32. PubMed ID: 30755254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eumycetoma by Madurella grisea. Report of the first case observed in the southern Brazilian region.
    Severo LC; Vetoratto G; Oliveira Fde M; Londero AT
    Rev Inst Med Trop Sao Paulo; 1999; 41(2):139-42. PubMed ID: 10413963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden.
    Ahmed AO; van Leeuwen W; Fahal A; van de Sande W; Verbrugh H; van Belkum A
    Lancet Infect Dis; 2004 Sep; 4(9):566-74. PubMed ID: 15336224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple extensive Madurella mycetomatis eumycetoma lesions: a case report and review of the literature.
    Zaid DM; Bakheet OE; Ahmed ES; Abdalati F; Mhmoud NA; Mohamed ESW; Bakhiet SM; Siddig EE; Fahal AH
    Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):411-414. PubMed ID: 33406268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eumycotic mycetoma caused by Madurella mycetomatis successfully treated with antifungals, surgery, and topical negative pressure therapy.
    Estrada-Chavez GE; Vega-Memije ME; Arenas R; Chavez-Lopez G; Estrada-Castañon R; Fernandez R; Hay R; Dominguez-Cherit J
    Int J Dermatol; 2009 Apr; 48(4):401-3. PubMed ID: 19335427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Madurella mycetomatis infection of the foot: a case report of a neglected tropical disease in a non-endemic region.
    Karrakchou B; Boubnane I; Senouci K; Hassam B
    BMC Dermatol; 2020 Jan; 20(1):1. PubMed ID: 31918687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma.
    Nyuykonge B; Siddig EE; Mhmoud NA; Nyaoke BA; Zijlstra EE; Verbon A; Bakhiet S; Fahal AH; van de Sande WWJ
    Mycoses; 2022 Dec; 65(12):1170-1178. PubMed ID: 36005544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis.
    Eadie K; Parel F; Helvert-van Poppel M; Fahal A; van de Sande W
    Trop Med Int Health; 2017 Jun; 22(6):696-702. PubMed ID: 28342219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo.
    Konings M; Eadie K; Strepis N; Nyuykonge B; Fahal AH; Verbon A; van de Sande WWJ
    Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37960934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of 21 cases of mycetoma from 1991 to 2014 in Rio de Janeiro, Brazil.
    Sampaio FM; Wanke B; Freitas DF; Coelho JM; Galhardo MC; Lyra MR; Lourenço MC; Paes RA; do Valle AC
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005301. PubMed ID: 28192433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella.
    Lim W; Konings M; Parel F; Eadie K; Strepis N; Fahal A; Verbon A; van de Sande WWJ
    Med Mycol; 2022 Feb; 60(2):. PubMed ID: 35064672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycetoma in north-western Yemen: Clinico-epidemiological and histopathological study.
    Khatri ML; Al Kubati SAS; Gaffer IA; Majeed SMA
    Indian J Dermatol Venereol Leprol; 2022; 88(5):615-622. PubMed ID: 35389029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive, aggressive mastoid bone eumycetoma: a treatment challenge.
    Yosif AA; Bakhiet SM; Abdalla TH; Mhmoud NA; Siddig EE; Fahal AH
    Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):431-435. PubMed ID: 33682008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Madurella mycetomatis-Induced Massive Shoulder Joint Destruction: A Management Challenge.
    Scolding PS; Abbas MA; Omer RF; Fahal AH
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004849. PubMed ID: 27490198
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary Madurella mycetomatis mycetoma secondary to knee eumycetoma, Senegal.
    Diongue K; Diallo MA; Sarr L; Seck MC; Bréchard L; Ndiaye M; Badiane AS; Ranque S; Ndiaye D
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009238. PubMed ID: 33764976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole.
    van de Sande WW; de Kat J; Coppens J; Ahmed AO; Fahal A; Verbrugh H; van Belkum A
    Microbes Infect; 2007 Jul; 9(9):1114-23. PubMed ID: 17644456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
    Nyuykonge B; Lim W; van Amelsvoort L; Bonifaz A; Fahal A; Badali H; Abastabar M; Verbon A; van de Sande W
    Mycoses; 2022 Jun; 65(6):650-655. PubMed ID: 35398930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim.
    Lim W; Eadie K; Konings M; Rijnders B; Fahal AH; Oliver JD; Birch M; Verbon A; van de Sande W
    J Antimicrob Chemother; 2020 Apr; 75(4):936-941. PubMed ID: 31904836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis.
    Fahal AH; Rahman IA; El-Hassan AM; Rahman ME; Zijlstra EE
    Trans R Soc Trop Med Hyg; 2011 Mar; 105(3):127-32. PubMed ID: 21247608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.